In-situ cytidine-deaminase activity and chromosome 1P deletion in human neuroblastoma cells

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 457-459

  Slingerland, R J ^a   Van Gennip, A H ^a   Bodlaender, J M ^a   Voute P A ^a   Van Kuilenburg, A B P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chromosome 1p; Cytidine deaminase; Human neuroblastoma cells; Uracil analogues

Indexed keywords

CYTIDINE DEAMINASE;

ALLELE; ARTICLE; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CYTIDINE; CYTIDINE DEAMINASE; HUMANS; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0031049173     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Philip T, Zucker JM, Bernard JL, Lutz P, Bordigoni P, Plouvier E, Robert A, Roche H, Souillet G, Bouffet E, Michon J, Lopez M, Vilcoq JM, Gentet JC, Philip I, Ladenstcin R, Favrot M and Chauvin F: Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol 9: 1037-1044, 1991.
2. Saccone S, Besati C, Andreozzi L, Delia Valle G, Garattini E and Terao M: Assignment of the human cytidine deaminase gone to chromosome 1 band p35p36.2. Genomics 22: 661-662, 1994.
3. Schwab M: Molecular cytogenetics of human neuroblastoma, Biochim Biophys Acta 1114: 43-50, 1992.
4. Daher GC, Harris BE and Diasio RB: Metabolism of pyrimidine analogues and their nucleosides [review], Pharmacol Ther 48: 189-222, 1990.
5. Lim M-L, Moyer JD, Cysyk RL and Marquez VE: cyclopentenyluridine and cyclopentenylcytidine analogues as inhibitors of uridine-cytidine kinase. J Med Chem 27: 1536-1538, 1984.
6. Moyer JD, Malinowski NM, Treanor SP and Marquez VE: Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice. Cancer Res 46: 3325-3329, 1986.
7. Slingerland RJ, Van Gennip AH, Bodlaender JM, Voute PA and Van Kuilenburg ABP: Quantitative analysis of the pyrimidine metabolism in pheoehromocytoma PC-12 cells. Eur J Biochem 23: 538-543, 1995.
8. Palmgren G, Mattsson O and Okkels FT: Employment of hydrolytic enzymes in the study of the level of DNA methylation. Biochem Biophys Acta 1049: 293-297, 1990.
9. Reynolds CP, Tomayko MM, Donner L et al: Biological classification of cell lines derived from human extra-cranial neural tumors. In: Advances in neurohlastoma research Vol 2., 1988. pp 291-306, Alan R. Liss, New York.
10. Biedler JL, Roffler-Tarlov S, Schachner M and Freedman LS: Multiple neurontransmitter synthesis by human neurohlastoma cell lines and clones. Cancer Res 38: 3751-3757, 1978.
11. Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F and Versteeg R: Deletion mapping in neuroblastomu cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10: 291-297, 1995.
12. Caron H, Peter M, Van Sluis P, Speleman F, De Kraker J, Laureys G, Michon J, Brugieres, Voute PA, Westerveld A, Slater R, Delattre O and Versteeg R: Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 43: 535-539, 1995.